SCHEMBL4145085

SCHEMBL4145085

CN(C(=O)NCc1ccco1)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.43
POLB P06746 5/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 2/20 0.42
ALDH1A1 P00352 3/20 0.41
EPHX2 P34913 1/20 0.41
MLYCD O95822 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.39
BLM P54132 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4144739 0.83 MAPT (0.46) HPGDMAPTSMN1; SMN2ALDH1A1EPHX2
SCHEMBL4142022 0.81 PTPRZ1 (0.37) MAPTSMN1; SMN2ALDH1A1EPHX2TSHR
SCHEMBL4150851 0.80 PTPRZ1 (0.36) MAPTALDH1A1EPHX2TSHRLMNA
SCHEMBL13774610 0.79 PTPRZ1 (0.39) MAPTALDH1A1EPHX2KMT2ALMNA
SCHEMBL4150041 0.78 ALDH1A1 (0.43) POLBMAPTSMN1; SMN2HSD17B10ALDH1A1
SCHEMBL4154163 0.78 KMT2A (0.44) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL4144820 0.78 PTPRZ1 (0.35) MAPTSMN1; SMN2EPHX2TSHRLMNA
SCHEMBL4149940 0.78 PTPRZ1 (0.35) MAPTEPHX2TSHRLMNA
SCHEMBL4149965 0.78 ACKR3 (0.38) SMN1; SMN2ALDH1A1EPHX2KMT2A
SCHEMBL4157346 0.78 HPGD (0.47) HPGDPOLBSMN1; SMN2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 HPGD 4852/4885POLB 4024/4885MAPT 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.